Zheng Quan Zhi Xing·2025-06-20 12:55Group 1 - The company plans to dispose of up to 3 million shares of Beijing Beilu Pharmaceutical Co., Ltd. through Shenzhen Stock Exchange within three months after the pre-disclosure announcement of the reduction plan [1][2] - The company has completed the disposal of 2,998,800 shares of Beilu Pharmaceutical from March 24, 2025, to June 19, 2025, at an average transaction price of 7.46 yuan per share, totaling a transaction amount of 22,364,330 yuan [1][2] Group 2 - After the disposal, the company still holds 37,465,700 shares of Beilu Pharmaceutical, which represents a significant portion of its holdings [2] - The transaction is expected to enhance the company's asset liquidity and efficiency, allowing it to focus resources on core business development, with an estimated net profit increase of approximately 12.25 million yuan after deducting costs and related transaction taxes [2]